Fennec Pharmaceuticals (FENC) Amortization of Deferred Charges (2019 - 2024)
Fennec Pharmaceuticals' (FENC) quarterly Amortization of Deferred Charges came in at $4000.0 in Q1 2024, down 80.0% YoY from $20000.0 in Q2 2023, and down 92.73% on a QoQ basis from $55000.0 in Q4 2023.
Powered by 
Analysis
Fennec Pharmaceuticals (FENC) Amortization of Deferred Charges (2019 - 2024) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 6 years of Amortization of Deferred Charges data on file, last reported at $4000.0 in Q1 2024.
- Quarterly Amortization of Deferred Charges fell 80.0% year-over-year to $4000.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $205000.0 (up 40.41% YoY) and the FY2024 annual result came in at $21000.0, down 90.5% from the prior year.
- Amortization of Deferred Charges fell to $4000.0 in Q1 2024, from $55000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $355000.0 in Q3 2020 to a low of $4000.0 in Q1 2024.
- A 5-year average of $55285.7 and a median of $25000.0 in 2020 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2020 — Amortization of Deferred Charges jumped 1988.24% — and 2021, when it sank 97.75%.
- Tracing FENC's Amortization of Deferred Charges over 5 years: stood at $355000.0 in 2020, then plunged by 98.03% to $7000.0 in 2021, then jumped by 685.71% to $55000.0 in 2022, then changed by 0.0% to $55000.0 in 2023, then plunged by 92.73% to $4000.0 in 2024.
- The last three Amortization of Deferred Charges figures came in at $4000.0 (Q1 2024), $55000.0 (Q4 2023), and $53000.0 (Q3 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Fennec Pharmaceuticals | 432.85 Mn | 391.60 Mn | 17.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | 55,000.00 |
| Sep 30, 2023 | 53,000.00 |
| Jun 30, 2023 | 93,000.00 |
| Mar 31, 2023 | 20,000.00 |
| Dec 31, 2022 | 55,000.00 |
| Sep 30, 2022 | 63,000.00 |
| Jun 30, 2022 | 8,000.00 |
| Mar 31, 2022 | 6,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Sep 30, 2020 | 355,000.00 |
| Jun 30, 2020 | 30,000.00 |
| Mar 31, 2020 | 17,000.00 |
| Dec 31, 2019 | 18,000.00 |
| Sep 30, 2019 | 17,000.00 |
| Jun 30, 2019 | 17,000.00 |
| Mar 31, 2019 | 12,000.00 |